active

Mandelic Acid

Also known as MandelicAcid
INCI: MANDELIC ACID
CAS 90-64-2 EC 202-007-6
Benzeneacetic acid, .alpha.-hydroxy-
Limited Data
Insufficient safety data available. Consider enriching this ingredient.
Details

Description

Benzeneacetic acid, .alpha.-hydroxy-

Purpose

Function

AHA exfoliant with highest MW among common AHAs (152 Da). Slower, more even skin penetration produces significantly less irritation than glycolic or lactic acid. Antibacterial activity against acne-causing organisms. Exfoliates without the aggressive brightening that can trigger rebound hyperpigmentation in darker skin tones. Key component of triple-acid peels (mandelic + salicylic + citric acid) validated in Fitzpatrick IV–V patients for acne and PIH treatment.
Profile

Properties

Silicone
Silicone free
Compliance

Regulatory Status

EU
Permitted
Safety
GOOD
US
Permitted
Absorptionmoderate
Sensitizationnone
MoSnot established
ConcernModerate
Flags
eu-unrestrictedno-cir-reviewno-sccs-opinionphototoxic
Verdict

Mandelic Acid (CAS 90-64-2) is an alpha-hydroxy acid permitted without restriction under EU Regulation (EC) No. 1223/2009 and US FD&C Act. Non-irritating to skin, LLNA negative, non-mutagenic. Key concerns: H318 serious eye damage classification; AHA-class photosensitivity (~18% increase in UV-induced skin sensitivity). Data gaps exist for NOAEL from repeated dose studies and reproductive/developmental toxicity.

US Note

Permitted cosmetic ingredient under FD&C Act. Not GRAS classified for OTC drug use. FDA 2005 AHA labeling guidance applies: products must include sun protection advisory (daily SPF use recommended). CIR 1998 report (reaffirmed 2017) evaluated glycolic and lactic acids but not mandelic acid specifically; comparable AHA safety conditions suggested (≤10% consumer, pH ≥3.5, sun protection). Not subject to any FDA concentration restriction as a cosmetic.

Assessment

Ratings

Comedogenic0/5
LowHigh
Irritancy0/5
LowHigh
Reference

Identifiers

CAS Number
90-64-2
EC Number
202-007-6
INCI
MANDELIC ACID
Category
active
Updated
Apr 2, 2026